Request Samples Contact Us Home About Us News + Events News + Events October 19, 2021 SWM International’s Scapa Healthcare Business Signs Exclusive Technology Licensing Agreement for Novel Wound Care Technology with Synedgen, Inc. ALPHARETTA, GA, October 19, 2021 – Scapa Healthcare, an SWM International (NYSE: SWM) business and the trusted strategic partner for the world’s leading companies in advanced wound care, consumer wellness, and medical device and fixation, and Synedgen Inc., a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, announced today that they have signed an exclusive worldwide licensing agreement for two novel innovative wound care treatments developed using Synedgen’s proprietary glycochemistry technology platform. The agreement also gives Scapa Healthcare the right to use Synedgen’s glycopolymer technology in conjunction with other wound care technologies. Under the terms of the agreement, Scapa Healthcare has exclusive rights over Synedgen’s glycopolymer technology in the field of dermal wounds and surgical care applications both over the counter and in the professional setting. The advanced glycopolymer-based wound cleanser and wound hydrogel formulae are proven to control infection and promote wound healing by limiting bacterial infection, disrupting mature biofilm, and reducing inflammation and scarring of acute and chronic wounds and surgical incisions. Developed with support from the Defense Health Agency (DHA) and the Defense Advanced Research Projects Agency (DARPA), these wound care products are FDA 510(k) cleared and offer substantial advances over existing wound cleansers and wound hydrogels products in the market. In addition to the two market-ready products, this technology offers a wide range of possibilities for customized wound management solutions in combination with other advanced wound care technologies including hydrocolloids, hydrogels, collagen and medical foam materials. “We are delighted to be entering into this agreement with Synedgen, a company that shares our commitment to deliver innovative medical solutions that truly enhance people’s lives” said John Petreanu, president of the Scapa Healthcare business. “This novel glycopolymer technology strengthens our portfolio of advanced wound care products and enables us to bring cutting-edge wound management solutions to our customers in a variety of formats leveraging our skin contact adhesive and topical technologies.” “This agreement with Scapa Healthcare will expand Synedgen’s effective approach to treating challenging wounds for patients worldwide,” said Shenda Baker, PhD, President and CEO of Synedgen. “With a rich Defense heritage, we have been able to create a new class of wound care products for warfighter and civilian use. We are honored to partner with such a well-known, world industry leader that adds to the level of consumer trust and experience to expand the application and distribution of this technology.” With development and manufacturing facilities throughout North America and Europe, Scapa Healthcare offers single-source, dual supply to its partners. Scapa Healthcare’s facilities are ISO-certified and FDA-registered with cleanrooms and environmentally controlled rooms for full-scale production of finished goods. In April 2021, Schweitzer-Mauduit International, Inc., known as SWM International, acquired Scapa Group PLC, including the Scapa Healthcare business. About SWM International: Schweitzer-Mauduit International, Inc., operating as SWM International, is a leading global performance materials company, focused on bringing best-in-class innovation, design, and manufacturing solutions to our customers. Our highly engineered films, adhesive tapes, foams, nets, nonwovens, and papers are designed and manufactured using resins, polymers, and natural fibers for a variety of industries and specialty applications. SWM and its subsidiaries manufacture on four continents, conduct business in over 90 countries and employ approximately 5,000 people worldwide. For further information, please visit SWM’s website at www.swmintl.com. SWM’s Scapa Healthcare business is the trusted strategic partner of choice for the world’s leading companies in advanced wound care, consumer wellness and medical device & fixation. Our strategy is to collaborate with industry leaders to develop and manufacture innovative skin friendly medical device fixation and topical solutions. Through pursuing these collaborations, Scapa now provides integrated services to the top global MedTech companies. Our state-of-the-art facilities enable Scapa Healthcare to offer customers the whole spectrum of production services from inception through to market delivery. For more information visit: scapahealthcare.com or email healthcare@scapa.com About Synedgen: Synedgen is a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system. The company’s lead development candidate is SYGN305 for gastrointestinal mucositis, where a large unmet need exists to prevent intestinal radiation injury, the single most important dose-limiting factor in cancer radiotherapy. Synedgen’s glycochemistry platform has already generated five FDA 510(k)-cleared therapeutics, one OTC drug, one veterinary indexed drug, and an out-licensed Phase 2 program, to Synspira, for the potential treatment of pulmonary complications of cystic fibrosis. Synedgen has research and manufacturing facilities in Claremont, California. For more information, please visit www.synedgen.com. SWM | Scapa Healthcare Media Contact Hillary Lima SVM Public Relations and Marketing Communications hillary.lima@svmpr.com (401) 490-9700 Synedgen, Inc. Media Contact Laurence Watts Gilmartin Group, LLC. laurence@gilmartinir.com (619) 916-7620 Share: More Press Releases November 3, 2021 SWM ANNOUNCES THIRD QUARTER 2021 RESULTS August 4, 2021 SWM ANNOUNCES SECOND QUARTER 2021 RESULTS June 24, 2021 SWM to Increase Prices for its Engineered Papers Portfolio to Offset Exceptional Market Pulp Cost Hike May 5, 2021 SWM ANNOUNCES FIRST QUARTER 2021 RESULTS We’re Here to Help. Contact Us. First Name Last Name Email Telephone Company Name Country Select Country Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua And Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia And Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Cook Islands Costa Rica Cote D'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Islas Malvinas) Faroe Islands Fiji Islands Finland France France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and McDonald Islands Honduras Hong Kong S.A.R. Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau S.A.R. Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Other-Not Shown Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Island Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Kitts And Nevis Saint Lucia Samoa San Marino Sao Tome And Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Helena Saint Pierre and Miquelon Sudan Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad And Tobago Tunisia Turkey Turkmenistan Turks And Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States(U.S.A.) US Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican City State (Holy See) Venezuela Vietnam Virgin Islands (British) Virgin Islands (US) Wallis And Futuna Islands Western Sahara Yemen Zaire Zambia Zimbabwe French West Indies Congo Saint Vincent And The Grenadines Main Market Interest Select One Agriculture Packaging & Beverage Consumer Goods Energy Erosion Control Filtration Healthcare Home Industrial Infrastructure Reverse Osmosis Safety Solutions Tobacco Transportation Other Main Product Interest Select One Films Netting Other Subscribe to Our Newsletter Comment (Limit: 400 characters) Submit Need more contact options? Visit our Contact Page All Fields Are Required Accept to SWM collects personal data (i.e., information that can be used to identify you) through your use of the Site. Additionally, personal data may be collected from comments and questions from visitors to the Site. This is a commercial website intended for use by individuals that are at least 16 years old. If you are less than 16 years old, you may not use this Site without the prior permission and supervision of your legal guardians. SWM does not accept members under the age of 13 and does not knowingly collect information from anyone under the age of 13 Products Engineered Composites Fibers & Yarn Film Netting Nonwovens Paper Soil Stabilization Tapes & Adhesives Tobacco Products Tubing & Parts Markets Agriculture Packaging & Beverage Consumer Goods Energy Erosion Control Filtration Healthcare Home Industrial Infrastructure Reverse Osmosis Safety Solutions Tobacco Transportation Expertise Manufacturing Excellence Custom Engineering Innovation Sustainability Success Stories About Us Our Story Careers Our Leaders News + Events Locations Governance Contact Us Request Samples Investor Relations Terms of Use Terms and Conditions Privacy Policy Purchase Order Terms and Conditions Sitemap Follow Us Learn more about the CA Transparency in Supply Chains Act and U.K. Modern Slavery Act This site uses cookies to store information on your computer. Some are essential to make our site work; others help us improve the user experience. By using this site, you consent to the placement of these cookies. Read our Privacy Policy to learn more. Agree and dismiss.